Skip to main content

Veeva Systems stock price and financials

  • VEEV · NYSE
  • Software
  • Health Care Technology
  • S&P 500
$301.53−0.29%Close 13 Nov 2026 · Next results 19 Nov 2026
Market value
$49.02B
P/E
48.31
EV / EBITDA
38.78
Beta · 1 year
0.50
Return · 1 year
+1.5%
52-week range$148.05 — $325.99

Share price close 16 Nov 2026

−3.3%1 monthHigh $323.04Low $301.53
$300$310$320$33023 Oct29 Oct4 Nov10 Nov16 Nov
+90.5%6 monthsHigh $323.04Low $153.16
$150$200$250$300$350Q1 FY2027 report filed 5 Jun 2026Q2 FY2027 report filed 27 Aug 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+35.5%year to dateHigh $323.04Low $151.43
$150$200$250$300$350Q4 FY2026 report filed 20 Mar 2026Q1 FY2027 report filed 5 Jun 2026Q2 FY2027 report filed 27 Aug 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+3.1%1 yearHigh $323.04Low $151.43
$150$200$250$300$350Q3 FY2026 report filed 21 Nov 2025Q4 FY2026 report filed 20 Mar 2026Q1 FY2027 report filed 5 Jun 2026Q2 FY2027 report filed 27 Aug 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+71.2%3 yearsHigh $323.04Low $151.43
$150$200$250$300$350Q3 FY2024 report filed 7 Dec 2023Q4 FY2024 report filed 25 Mar 2024Q1 FY2025 report filed 4 Jun 2024Q2 FY2025 report filed 4 Sep 2024Q3 FY2025 report filed 9 Dec 2024Q4 FY2025 report filed 24 Mar 2025Q1 FY2026 report filed 2 Jun 2025Q2 FY2026 report filed 29 Aug 2025Q3 FY2026 report filed 21 Nov 2025Q4 FY2026 report filed 20 Mar 2026Q1 FY2027 report filed 5 Jun 2026Q2 FY2027 report filed 27 Aug 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+628%10 yearsHigh $338.82Low $40.70
$0$100$200$300$400Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Veeva Systems reported revenue of $3.20 billion for fiscal year 2026 (the twelve months to 31 Jan 2026), up 16.3% from fiscal 2025. Net income was $909 million and diluted earnings per share $5.44.

In its latest reported quarter, the second quarter of fiscal 2027 (the three months to 31 Jul 2026), revenue was $928 million, up 17.6% from a year earlier.

Figures from Veeva Systems's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 27 Aug 2026.

Against Health Care

Growth
Top 10%
Revenue +16.9% a year over five years · 4th of 37
Profitability
Top 10%
Return on invested capital 29.0%, five-year average · 2nd of 38
Balance sheet
Top 10%
More cash than debt · 1st of 38
Valuation
Dearer than most
P/E 48.3 · 28th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2026
$3.20B+16.3%
Net income
$908.9M+27.3%
Diluted EPS
$5.44+25.9%
Gross margin
75.5%+1.0 pts
Free cash flow
$1.39B+29.6%
Net cash
$6.46B

Fiscal 2026 against fiscal 2025; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2017–2026

  • Revenue
  • Net income
$0$1B$2B$3B$4BRevenue, FY17: $550.54MNet income, FY17: $77.57MFY17Revenue, FY18: $690.56MNet income, FY18: $151.18MFY18Revenue, FY19: $862.21MNet income, FY19: $229.83MFY19Revenue, FY20: $1.1BNet income, FY20: $301.12MFY20Revenue, FY21: $1.47BNet income, FY21: $380MFY21Revenue, FY22: $1.85BNet income, FY22: $427.39MFY22Revenue, FY23: $2.16BNet income, FY23: $487.71MFY23Revenue, FY24: $2.36BNet income, FY24: $525.71MFY24Revenue, FY25: $2.75BNet income, FY25: $714.14MFY25Revenue, FY26: $3.2BNet income, FY26: $908.91MFY26

Latest quarter · Q2 FY2027 to 31 Jul 2026, filed 27 Aug 2026 · Full results →

Revenue
$928.0M+17.6% on a year
Gross margin
75.0%−0.3 pts on a year
Operating income
$275.0M+40.4% on a year
Net income
$273.4M+36.5% on a year
Diluted EPS
$1.66+39.5% on a year
Free cash flow
$230.7M−0.6% on a year

Comparable companies All of Health Care →

Veeva Systems beside the other S&P 500 members in Health Care Technology, then the largest in Health Care, by market value.

Veeva Systems and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
Veeva SystemsVEEV$49.02B−0.3%+1.5%+16.5%29.3%48.3
SolventumSOLV—+0.3%+20.7%———
Eli LillyLLY$1.37T+1.1%+41.8%+45.5%31.9%49.6
Johnson & JohnsonJNJ$686.1B+0.8%+47.0%+7.8%16.2%42.6
AbbVieABBV$525.9B+0.2%+26.5%+10.7%15.7%51.1
AmgenAMGN$253.8B−0.3%+38.5%+8.2%24.1%27.0
Gilead SciencesGILD$210.2B+0.1%+36.2%+6.5%−12.5%—

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2017–2026

  • Gross
  • Operating
  • Net
0%50%100%75.5%28.7%28.4%FY17FY20FY23FY26

Veeva Systems revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By product

Veeva Systems revenue by product, by fiscal year
RevenueFY 2022FY 2023FY 2024FY 2025FY 2026
R&D and Quality Solutions$607.5M$786.8M+29.5%$905.8M+15.1%$1.18B+30.2%$1.43B+20.9%
Commercial Solutions$876.5M$946.3M+8.0%$995.8M+5.2%$1.10B+11.0%$1.26B+13.8%
Professional services and other$366.8M$422.1M+15.1%$462.1M+9.5%$462.0M−0.0%$511.1M+10.6%
Total revenue$1.85B$2.16B$2.36B$2.75B$3.20B

By region

Veeva Systems revenue by region, by fiscal year
RevenueFY 2022FY 2023FY 2024FY 2025FY 2026
North America$1.06B$1.25B+17.9%$1.39B+10.7%$1.62B+16.9%$1.90B+17.4%
Europe$509.1M$598.8M+17.6%$662.6M+10.6%$790.8M+19.4%$939.6M+18.8%
Asia Pacific$226.0M$244.7M+8.3%$250.6M+2.4%$265.7M+6.0%$280.2M+5.4%
Other international$51.91M$57.82M+11.4%$63.09M+9.1%$68.41M+8.4%$72.18M+5.5%
Total revenue$1.85B$2.16B$2.36B$2.75B$3.20B

Financial statements

Fiscal years, the latest ending 31 Jan 2026. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Veeva Systems income statement, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Revenue$550.5M$690.6M$862.2M$1.10B$1.47B$1.85B$2.16B$2.36B$2.75B$3.20B
Revenue growth+34.5%+25.4%+24.9%+28.1%+32.7%+26.3%+16.4%+9.7%+16.2%+16.3%
Gross profit$376.9M$479.1M$616.9M$800.7M$1.06B$1.35B$1.55B$1.69B$2.05B$2.41B
Operating income$120.7M$157.9M$222.9M$286.2M$377.8M$505.5M$459.1M$429.3M$691.4M$916.4M
Net income$77.57M$151.2M$229.8M$301.1M$380.0M$427.4M$487.7M$525.7M$714.1M$908.9M
Diluted EPS$0.53$0.98$1.47$1.90$2.36$2.63$3.00$3.22$4.32$5.44
Gross margin68.5%69.4%71.6%72.5%72.1%72.8%71.7%71.3%74.5%75.5%
Operating margin21.9%22.9%25.8%25.9%25.8%27.3%21.3%18.2%25.2%28.7%
Net margin14.1%21.9%26.7%27.3%25.9%23.1%22.6%22.2%26.0%28.4%

Cash flow

Veeva Systems cash flow, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Operating cash flow$144.0M$233.4M$310.8M$437.4M$551.2M$764.5M$780.5M$911.3M$1.09B$1.42B
Capital expenditure$6.92M$9.63M$9.82M$4.32M$8.68M$14.21M$13.51M$26.20M$20.52M$29.13M
Free cash flow$137.1M$223.8M$301.0M$433.1M$542.6M$750.2M$767.0M$885.1M$1.07B$1.39B

Balance sheet and shares

Veeva Systems balance sheet and shares, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Cash and equivalents$217.6M$320.2M$551.0M$476.7M$730.5M$1.14B$886.5M$703.5M$1.12B$1.42B
Total debt$0.00$0.00$0.00$54.83M$62.74M$54.59M$60.98M$55.77M$75.78M$95.86M
Shareholders' equity$652.7M$906.2M$1.24B$1.67B$2.27B$2.91B$3.72B$4.64B$5.83B$7.21B
Diluted shares148M154M156M158M161M162M162M163M165M167M

Quarterly figures

The last eight fiscal quarters, the latest ending 31 Jul 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Veeva Systems quarterly financial figures
PeriodQ3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027Q2 FY2027
Revenue$699.2M$720.9M$759.0M$789.1M$811.2M$836.0M$882.9M$928.0M
Revenue, year on year+13.4%+14.3%+16.7%+16.7%+16.0%+16.0%+16.3%+17.6%
Gross margin75.1%74.9%77.1%75.3%75.4%74.5%75.0%75.0%
Operating income$181.4M$188.4M$233.7M$195.9M$240.9M$245.9M$273.1M$275.0M
Net income$185.8M$195.6M$228.2M$200.3M$236.2M$244.2M$260.9M$273.4M
Diluted EPS$1.13$1.18$1.37$1.19$1.40$1.49$1.57$1.66
Free cash flow$159.8M$64.82M$871.2M$232.1M$182.9M$99.82M$1.13B$230.7M

Operating KPIs

The operating figures Veeva Systems reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Veeva Systems operating KPIs
KPILatestPeriodChange on a yearRecent periods
Subscription revenue$766.8Mquarter to 31 Jul 2026up 16.3%
R&D and Quality Solutions revenue$419.4Mquarter to 31 Jul 2026up 19.3%
Commercial Solutions revenue$347.4Mquarter to 31 Jul 2026up 13.0%
Professional services and other revenue$161.2Mquarter to 31 Jul 2026up 24.1%
North America revenue$549.2Mquarter to 31 Jul 2026up 17.3%
Europe revenue$283.9Mquarter to 31 Jul 2026up 22.0%
Asia Pacific revenue$76.3Mquarter to 31 Jul 2026up 8.8%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Veeva Systems's revenue in fiscal 2026?

$3.20 billion for fiscal year 2026 (the twelve months to 31 Jan 2026), as reported in its annual report.

What was Veeva Systems's net income in fiscal 2026?

$909 million for fiscal year 2026 (the twelve months to 31 Jan 2026).

What were Veeva Systems's diluted earnings per share in fiscal 2026?

$5.44 for fiscal year 2026 (the twelve months to 31 Jan 2026).

What is Veeva Systems's gross margin?

75.5% for fiscal year 2026 (the twelve months to 31 Jan 2026): gross profit divided by revenue.

What is Veeva Systems's operating margin?

28.7% for fiscal year 2026 (the twelve months to 31 Jan 2026): operating income divided by revenue.

How much free cash flow did Veeva Systems generate in fiscal 2026?

$1.39 billion for fiscal year 2026 (the twelve months to 31 Jan 2026): operating cash flow less capital expenditure.

Where does Veeva Systems's revenue come from?

In fiscal 2026, by product: R&D and Quality Solutions $1.43B (45%), Commercial Solutions $1.26B (39%), Professional services and other $511.1M (16%), out of $3.20B in all, as stated in its annual report.

In the terminal

Twenty years of Veeva Systems's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans